FDA's Coté, Director Of Orphan Products Development Office, Jumps To NORD
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA will search for a new chief of its office just as interest in the rare disease space is increasing, particularly among large pharmaceutical companies.